Patents by Inventor Max Grosse
Max Grosse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250054042Abstract: Systems, methods, and computer-readable storage media for predicting user interest, and more specifically to defining user interest based on user expressions of intent. The system can receive a list of items, where each item in the list of items has a similar purpose and can be substituted with other items in the list of items, and item content elements associated with items in the list. The system can then identify websites with content that is relevant to the item content elements associated with the list based on relevancy, and identify at least one user that accessed one of the websites, resulting in at least one interested user. The system can then generate, for each user in the set of at least one interested users, a user intent and modify a previously planned interaction with the each user based on the user intent score.Type: ApplicationFiled: August 8, 2024Publication date: February 13, 2025Inventors: Brendan Brady, Jun Hong Choi, Manoj Kumar Goyal, Max Gross, Kumaran Ramanathan, Jason Ryan Tenenbown
-
Publication number: 20240150005Abstract: A floor panel for installation in an aircraft includes a plurality of thermoplastic C-shaped stringers, a consolidated thermoplastic deltoid filler, a thermoplastic upper facing sheet, and a thermoplastic lower facing sheet. The stringers are disposed in a parallel arrangement with one another. The deltoid filler is disposed within a longitudinally-extending notch defined by a pair of adjacent stringers. The upper facing sheet covers an upper surface of the stringers and the deltoid filler. The lower facing sheet covers a lower surface of the stringers and the deltoid filler. The stringers, the deltoid filler, and the upper and lower facing sheets are integrally consolidated forming a unitary construction.Type: ApplicationFiled: January 9, 2024Publication date: May 9, 2024Inventors: Max Gross, Joseph Bruno
-
Patent number: 11866148Abstract: A floor panel for installation in an aircraft includes a plurality of thermoplastic C-shaped stringers, a consolidated thermoplastic deltoid filler, a thermoplastic upper facing sheet, and a thermoplastic lower facing sheet. The stringers are disposed in a parallel arrangement with one another. The deltoid filler is disposed within a longitudinally-extending notch defined by a pair of adjacent stringers. The upper facing sheet covers an upper surface of the stringers and the deltoid filler. The lower facing sheet covers a lower surface of the stringers and the deltoid filler. The stringers, the deltoid filler, and the upper and lower facing sheets are integrally consolidated forming a unitary construction.Type: GrantFiled: August 31, 2020Date of Patent: January 9, 2024Assignee: SCIMAX TECHNOLOGIES, LLCInventors: Max Gross, Joseph Bruno
-
Patent number: 11716376Abstract: A system for managing non-linear transmedia content data is provided. Memory stores a plurality of transmedia content data items and associated linking data which define time-ordered content links between the plurality of transmedia content data items. The plurality of transmedia content data items are arranged into linked transmedia content subsets comprising different groups of the transmedia content data items and different content links therebetween. A control engine receives one or more instructions to create a new time-ordered content link between at least two of the plurality of transmedia content data items. The control engine modifies the linking data stored in the memory to include the new time-ordered content link.Type: GrantFiled: September 26, 2016Date of Patent: August 1, 2023Assignees: DISNEY ENTERPRISES, INC., ETH ZÜRICH (EIDGENÖSSISCHE TECHNISCHE HOCHSCHULE ZÜRICH)Inventors: Max Grosse, Barbara Solenthaler, Peter Kaufmann, Markus Gross, Sasha Schriber
-
Patent number: 11297396Abstract: The invention relates to systems and methods for manipulating non-linearly connected transmedia content, in particular for creating, processing and/or managing non-linearly connected transmedia content and for tracking content creation and attributing transmedia content to one or more creators. Specifically, the invention involves creating a transmedia content data item by a first user and storing the transmedia content data item in a data store, along with a record indicating an association between the first user and the transmedia content data item; creating an ordered group of transmedia content data items by a second user, the ordered group comprising a pointer to the transmedia content data item of the first user; and storing the ordered group and a record associating both the first user and the second user with the ordered group in the data store.Type: GrantFiled: September 26, 2017Date of Patent: April 5, 2022Assignee: Disney Enterprises, Inc.Inventors: Rebekkah Laeuchli, Sasha Schriber, Stephan Veen, Markus Gross, Isabel Simo, Max Grosse
-
Patent number: 11269941Abstract: Systems and methods are provided for a workflow framework that scriptwriters can utilize when developing scripts. A script can be parsed to identify one or more elements in a script, and various visual representations of the one or more elements and/or a scene characterized in the script can be automatically generated. A user may develop or edit the script which can be presented in a visual and temporal manner. Information parsed from the script can be stored in basic information elements, and used to create a knowledge bases.Type: GrantFiled: October 9, 2018Date of Patent: March 8, 2022Assignee: Disney Enterprises, Inc.Inventors: Sasha Anna Schriber, Rushit Sanghrajka, Wojciech Witon, Isabel Simo, Mubbasir Kapadia, Markus Gross, Daniel Inversini, Max Grosse, Eleftheria Tsipidi
-
Patent number: 11236084Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.Type: GrantFiled: July 4, 2018Date of Patent: February 1, 2022Assignee: Janssen Pharmaceutica NVInventors: George Hynd, Calum Macleod, Samuel Edward Mann, Janusz Jozef Kulagowski, Ian Stansfield, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel
-
Patent number: 11186589Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.Type: GrantFiled: February 6, 2020Date of Patent: November 30, 2021Assignee: Janssen Pharmaceutica NVInventors: Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Simon Richard Green, George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann
-
Patent number: 11180487Abstract: The present invention relates to pharmaceutical agents of formula (I) useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.Type: GrantFiled: January 20, 2017Date of Patent: November 23, 2021Assignee: Janssen Pharmaceutica NVInventors: Ian Stansfield, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann, Simon Richard Green, George Hynd
-
Patent number: 11136311Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.Type: GrantFiled: June 29, 2017Date of Patent: October 5, 2021Assignee: Janssen Pharmaceutica NVInventors: Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Simon Richard Green, George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann
-
Publication number: 20210188840Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoinmmune disorders.Type: ApplicationFiled: July 4, 2018Publication date: June 24, 2021Inventors: George HYND, Calum MACLEOD, Samuel Edward MANN, Janusz Jozef KULAGOWSKI, Ian STANSFIELD, Olivier Alexis Georges QUEROLLE, Virginie Sophie PONCELET, Gerhard Max GROSS, Edgar JACOBY, Lieven MEERPOEL
-
Patent number: 11001569Abstract: The present invention relates to pharmaceutical agents of formula (I), useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as a cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.Type: GrantFiled: January 20, 2017Date of Patent: May 11, 2021Assignee: Janssen Pharmaceutica NVInventors: Ian Stansfield, Olivier Alexis Georges Querolle, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann, Simon Richard Green, George Hynd
-
Patent number: 10977287Abstract: Systems and methods are provided for a workflow framework that scriptwriters can utilize when developing scripts. A script can be parsed to identify one or more elements in a script, and various visual representations of the one or more elements and/or a scene characterized in the script can be automatically generated. A user may develop or edit the script which can be presented in a visual and temporal manner. Information parsed from the script can be stored in basic information elements, and used to create a knowledge bases.Type: GrantFiled: October 9, 2018Date of Patent: April 13, 2021Assignee: Disney Enterprises, Inc.Inventors: Sasha Anna Schriber, Isabel Simo, Justine Fung, Daniel Inversini, Carolina Ferrari, Max Grosse, Markus Gross
-
Publication number: 20210087182Abstract: The present invention relates to pharmaceutical agents of formula (I) useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-KB-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.Type: ApplicationFiled: January 20, 2017Publication date: March 25, 2021Inventors: Ian STANSFIELD, Olivier Alexis Georges QUEROLLE, Virginie Sophie PONCELET, Gerhard Max GROSS, Edgar JACOBY, Lieven MEERPOEL, Janusz Jozef KULAGOWSKI, Calum MACLEOD, Samuel Edward MANN, Simon Richard GREEN, George HYND
-
Publication number: 20210060125Abstract: The present description relates to methods of treatment and pharmaceutical compositions comprising a Nitric Oxide Synthase-inducer peptide, PnPP-19. Although usable for other purposes, the composition comprising PnPP-19 is useful for treating and/or preventing eye diseases related to intraocular hypertension and/or optic nerve degeneration, such as glaucoma.Type: ApplicationFiled: September 1, 2020Publication date: March 4, 2021Inventors: Armando da Silva Cunha Junior, Maria Elena de Lima Perez Garcia, Carolina Nunes da Silva, Lays Fernanda Nunes Dourado, Perla Villani Borges da Silva, Paulo Gustavo Sampaio Lacativa, Gerhard Max Gross, Iron Francisco de Paula Junior
-
Publication number: 20210032267Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.Type: ApplicationFiled: February 6, 2020Publication date: February 4, 2021Inventors: Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Simon Richard Green, George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann
-
Patent number: 10905738Abstract: Synthetic peptides that are modulators of smooth muscle tone and compositions thereof, including pharmaceutical compositions containing a peptide, make it possible to treat indications in those in need of modulation of the smooth muscle tone, including, for example, benign prostate hyperplasia (BPH), Raynaud's syndrome, Pulmonary Arterial hypertension (PAH), systemic arterial hypertension (SAH) and hyper-reactivity of airways associated with asthma, COPD, pulmonary fibrosis, silicosis, allergic bronchopulmonary aspergillosis, hereditary angioedema, and neonatal hypoxemic respiratory failure. Although makeable in other ways, the synthetic peptides are makeable by recombinant methods or synthetic pathways.Type: GrantFiled: July 3, 2019Date of Patent: February 2, 2021Assignee: Biozeus Desenvolvimento De Produtos BiofarmacêuticosInventors: Caio Victor Machado França do Nascimento, Diego Allonso Rodrigues dos Santos da Silva, Perla Villani Borges da Silva, Maria Elena De Lima Perez Garcia, Carolina Nunes da Silva, Adriano Monteiro de Castro Pimenta, Marcella Nunes de Melo Braga, Paulo Gustavo Sampaio Lacativa, Iron Francisco de Paula Junior, Gerhard Max Gross
-
Publication number: 20210016899Abstract: A floor panel for installation in an aircraft includes a plurality of thermoplastic C-shaped stringers, a consolidated thermoplastic deltoid filler, a thermoplastic upper facing sheet, and a thermoplastic lower facing sheet. The stringers are disposed in a parallel arrangement with one another. The deltoid filler is disposed within a longitudinally-extending notch defined by a pair of adjacent stringers. The upper facing sheet covers an upper surface of the stringers and the deltoid filler. The lower facing sheet covers a lower surface of the stringers and the deltoid filler. The stringers, the deltoid filler, and the upper and lower facing sheets are integrally consolidated forming a unitary construction.Type: ApplicationFiled: August 31, 2020Publication date: January 21, 2021Inventors: Max Gross, Joseph Bruno
-
Patent number: 10759513Abstract: A floor panel for installation in an aircraft includes a plurality of thermoplastic C-shaped stringers, a consolidated thermoplastic deltoid filler, a thermoplastic upper facing sheet, and a thermoplastic lower facing sheet. The stringers are disposed in a parallel arrangement with one another. The deltoid filler is disposed within a longitudinally-extending notch defined by a pair of adjacent stringers. The upper facing sheet covers an upper surface of the stringers and the deltoid filler. The lower facing sheet covers a lower surface of the stringers and the deltoid filler. The stringers, the deltoid filler, and the upper and lower facing sheets are integrally consolidated forming a unitary construction.Type: GrantFiled: June 16, 2017Date of Patent: September 1, 2020Assignee: SCIMAX TECHNOLOGIES, LLCInventors: Max Gross, Joseph Bruno
-
Patent number: 10706097Abstract: The invention relates to systems and methods for navigating, outputting and displaying non-linearly connected groups of transmedia content. Specifically, the invention involves retrieving, from a database, an ordered group of transmedia content data objects comprising a plurality of transmedia content data objects and linking data, whereby each element of the linking data defines a directional link from one of the transmedia content data objects to another of the transmedia content data objects; generating a two-dimensional graph structure representing the ordered group of transmedia content data objects whereby each graph node corresponds to a transmedia content data object and each graph edge corresponds to an element of the linking data; and outputting the graph structure on a display screen.Type: GrantFiled: September 26, 2017Date of Patent: July 7, 2020Assignee: Disney Enterprises, Inc.Inventors: Rebekkah Laeuchli, Isabel Simo, Max Grosse, Markus Gross, Sasha Schriber, Maria Cabral, Merada Richter